II. Epidemiology of Pruritus in Chronic Renal Failure
- Pruritus affects 40-86% of Hemodialysis patients
- Affects 25% of non-dialysis Renal Failure patients
- Provocative
- Worse in summer
- Variable association with Dialysis timing
III. Pathophysiology
- Proposed mechanisms specific to Renal Failure
- Secondary Hyperparathyroidism and Hypercalcemia
- Hyperphosphatemia
- Aluminum overload
- Mast Cell proliferation
- Plasma Histamine level increases
- Sebaceous Gland atrophy
- Eccrine Sweat Gland atrophy
- Microangiopathy
- Other mechanisms from comorbid conditions
IV. Symptoms
VI. Management
-
General measures
- Hypoallergenic Skin Lubricant applied 2-4 times daily
- Topical Anesthetic
- Pramoxine Hydrochloride 1% (CeraVe itch relief)
- Topical Capsaicin 0.0255%
- Gabapentin 100 mg after each Dialysis session
- Other treatments that have been effective
- Ultraviolet (UV) Light Therapy
- Ultraviolet B
- Ultraviolet A with Psoralen (PUVA)
- Polidocanol (balneotherapy)
- Activated Charcoal 6 grams per day
- Cimetidine
- Cholestyramine
- Montelukast (Singulair)
- Selective Serotonin Reuptake Inhibitors (Sertraline)
- Ultraviolet (UV) Light Therapy
- Ineffective therapies
- Poor response to Antihistamines
- No relief with Naltrexone
- No relief with Ondansetron
- No relief with Phosphorus binding or other Phosphorus lowering
VII. References
- (2017) Presc Lett 24(11): 62-3
- Ashmore (2000) Am J Kidney Dis 35(5):827-31 [PubMed]
- Combs (2015) Semin Nephrol 35(4):383-91 +PMID:26355256 [PubMed]
- Gilchrest (1982) Arch Dermatol 118(3):154-6 [PubMed]
- Kam (1996) Anaesthesia 51:1133-38 [PubMed]
- Pauli-Magnus (2000) Clin Nephrol 11(3):514-9 [PubMed]
- Ponticelli (1992) Nephron 60:1-5 [PubMed]
- Schwartz (2000) Semin Dial 13(3):177-80 [PubMed]
- Shirazian (2017) Int J Nephrol Renovasc Dis 10:11-26 +PMID:28176969 [PubMed]
- Szepietowski (1998) Int J Dermatol 37(4):247-53 [PubMed]